The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of microsatellite instability (MSI-H) identified on liquid biopsy in advanced gastrointestinal cancers (aGI).
 
Pashtoon Murtaza Kasi
Consulting or Advisory Role - AstraZeneca; Axiom Healthcare Strategies; Bayer; Boston Healthcare Associates; Delcath Systems; Foundation Medicine; Inflecton Point Biomedical Advisors; Ipsen (Inst); Lilly; MSD Oncology; Natera; QED Therapeutics; Taiho Pharmaceutical (Inst); Tempus
Research Funding - Advanced Accelerator Applications (Inst); Array BioPharma (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Samuel J Klempner
Stock and Other Ownership Interests - TP Therapeutics
Honoraria - Natera
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Foundation Medicine; Lilly; Merck; Pieris Pharmaceuticals
Speakers' Bureau - Foundation Medicine
Research Funding - BeiGene (Inst); Leap Therapeutics (Inst)
Other Relationship - NCCN
 
Jason S. Starr
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Natera; Pfizer; Taiho Oncology; Tersera
Research Funding - Incyte (Inst); Leap Therapeutics; Macrogenics (Inst); Merus (Inst); Molecular Templates (Inst); Rafael Pharmaceuticals (Inst); Vedanta Biosciences (Inst)
 
Ardaman Shergill
Consulting or Advisory Role - Catalyst Pharmaceuticals; Triptych Health Partners
Research Funding - Daiichi Sankyo/Lilly (Inst); Hutchison MediPharma (Inst); InhibRx (Inst); Merck (Inst); Seattle Genetics/Astellas (Inst); TP Therapeutics (Inst); verastem (Inst)
 
Leslie A. Bucheit
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Caroline Weipert
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Jiemin Liao
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Jing Zhao
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Aaron Hardin
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Nicole Zhang
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Kathryn Lang
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Dialectica
Travel, Accommodations, Expenses - Guardant Health